The DOI matches its Crossref record; 97 of the 97 references it cites were found in a registry or an index.
A proteomic study of serum from children with autism showing differential expression of apolipoproteins and complement proteins
Abstract
Modern methods that use systematic, quantitative and unbiased approaches are making it possible to discover proteins altered by a disease. To identify proteins that might be differentially expressed in autism, serum proteins from blood were subjected to trypsin digestion followed by liquid chromatography-electrospray ionization-mass spectrometry (LC-ESI-MS) on time-of-flight (TOF) instruments to identify differentially expressed peptides. Children with autism 4-6 years of age (n=69) were compared to typically developing children (n=35) with similar age and gender distributions. A total of 6348 peptide components were quantified. Of these, five peptide components corresponding to four known proteins had an effect size >0.99 with a P<0.05 and a Mascot identification score of 30 or greater for autism compared to controls. The four proteins were: Apolipoprotein (apo) B-100, Complement Factor H Related Protein (FHR1), Complement C1q and Fibronectin 1 (FN1). In addition, apo B-100 and apo A-IV were higher in children with high compared to low functioning autism. Apos are involved in the transport of lipids, cholesterol and vitamin E. The complement system is involved in the lysis and removal of infectious organisms in blood, and may be involved in cellular apoptosis in brain. Despite limitations of the study, including the low fold changes and variable detection rates for the peptide components, the data support possible differences of circulating proteins in autism, and should help stimulate the continued search for causes and treatments of autism by examining peripheral blood.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Elevated plasma cytokine levels (IL-1β, IL-6, IL-12p40 and TNFα) [82–84], altered immunoglobulin levels [85, 86], elevated levels of complement proteins [87], and increased chemokine levels (CCL2, CCL5 and CCL11) [88] are reported in the plasma of young children with AD compared with matched typically developing children.”
From Consensus Paper: Pathological Role of the Cerebellum in Autism (2012) · cites this paper as [87]
Citations
Cites
A Simple Sequentially Rejective Multiple Test Procedure
(1979) · Scandinavian Journal of Statistics · doi:10.2307/4615733 · Cited by 21,526
Lord, C., Rutter, M., & Le Couteur, A. (1994) · Journal of Autism and Developmental Disorders · doi:10.1007/bf02172145 · Cited by 9,065
Perkins, D. N., Pappin, D., Creasy, D. M., & Cottrell, J. S. (1999) · Electrophoresis · doi:10.1002/(sici)1522-2683(19991201)20:18 · Cited by 8,264
Lord, C., Risi, S., Lambrecht, L., Cook, E. H., Leventhal, B. L., DiLavore, P. C., Pickles, A., & Rutter, M. (2000) · Journal of Autism and Developmental Disorders · doi:10.1023/a:1005592401947 · Cited by 7,520
Neuroglial activation and neuroinflammation in the brain of patients with autism
Vargas, D. L., Nascimbene, C., Krishnan, C., Zimmerman, A. W., & Pardo, C. A. (2005) · Annals of Neurology · doi:10.1002/ana.20315 · Cited by 2,149
Searching for genetic determinants in the new millennium
Risch, N. J. (2000) · Nature · doi:10.1038/35015718 · Cited by 1,839
Stanford-Binet Intelligence Scale
(2012) · Springer eBooks · doi:10.1007/springerreference_70151 · Cited by 1,671
An overview of the immune system
Parkin, J., & Cohen, B. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04904-7 · Cited by 1,593
Autism screening questionnaire: diagnostic validity
Berument, S. K., Rutter, M., Lord, C., Pickles, A., & Bailey, A. (1999) · British Journal of Psychiatry · doi:10.1192/bjp.175.5.444 · Cited by 1,464
Practice parameter: Screening and diagnosis of autism
Filipek, P. A., Accardo, P., Ashwal, S., Baranek, G. T., Cook, E. H., Dawson, G., Gordon, B., Gravel, J. S., Johnson, C. P., Kallen, R. J., et al. (2000) · Neurology · doi:10.1212/wnl.55.4.468 · Cited by 1,106
Genetics of austim: complex aetiology for a heterogeneous disorder
Folstein, S. E., & Rosen-Sheidley, B. (2001) · Nature Reviews Genetics · doi:10.1038/35103559 · Cited by 771
Bailey, A. J., Phillips, W., & Rutter, M. L. (1996) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.1996.tb01381.x · Cited by 765
The role of inflammation in Alzheimer’s disease
Tuppo, E. E., & Arias, H. R. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.07.009 · Cited by 734
A Genomic Screen of Autism: Evidence for a Multilocus Etiology
Risch, N., Spiker, D., Lotspeich, L., Nouri, N., Hinds, D., Hallmayer, J., Kalaydjieva, L., McCague, P., Dimiceli, S., Pitts, T., et al. (1999) · The American Journal of Human Genetics · doi:10.1086/302497 · Cited by 684
Stanford-Binet Intelligence Scale.
Paolitto, A. W., & Naglieri, J. A. (2000) · Oxford University Press eBooks · doi:10.1037/10522-192 · Cited by 674
Wang, W., Zhou, H., Lin, H., Roy, S., Shaler, T. A., Hill, L. R., Norton, S. M., Kumar, P., Anderle, M., & Becker, C. H. (2003) · Analytical Chemistry · doi:10.1021/ac026468x · Cited by 664
Korb, L. C., & Ahearn, J. M. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.10.4525 · Cited by 659
Baggerly, K., Morris, J. S., & Coombes, K. R. (2004) · Bioinformatics · doi:10.1093/bioinformatics/btg484 · Cited by 607
McConnell, S. R. (2002) · Journal of Autism and Developmental Disorders · doi:10.1023/a:1020537805154 · Cited by 579
The human complement factor H: functional roles, genetic variations and disease associations
de Córdoba, S. R., Esparza-Gordillo, J., GOICOECHEADEJORGE, E., López‐Trascasa, M., & Sánchez‐Corral, P. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2004.02.005 · Cited by 574
Lord, C., Cook, E. H., Leventhal, B. L., & Amaral, D. G. (2000) · Neuron · doi:10.1016/s0896-6273(00)00115-x · Cited by 555
Postmortem brain abnormalities of the glutamate neurotransmitter system in autism
Purcell, A. E., Jeon, O. H., Zimmerman, A. W., Blue, M. E., & Pevsner, J. (2001) · Neurology · doi:10.1212/wnl.57.9.1618 · Cited by 518
Reelin Is a Secreted Glycoprotein Recognized by the CR-50 Monoclonal Antibody
D’Arcangelo, G., Nakajima, K., Miyata, T., Ogawa, M., Mikoshiba, K., & Curran, T. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-01-00023.1997 · Cited by 515
Proteomics: new perspectives, new biomedical opportunities
Banks, R. E., Dunn, M. J., Hochstrasser, D. F., Sanchez, J., Blackstock, W. P., Pappin, D., & Selby, P. J. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03214-1 · Cited by 451
Evidence-Based Assessment of Autism Spectrum Disorders in Children and Adolescents
Ozonoff, S. J., Goodlin‐Jones, B. L., & Solomon, M. (2005) · Journal of Clinical Child & Adolescent Psychology · doi:10.1207/s15374424jccp3403_8 · Cited by 443
Jyonouchi, H., Sun, S., & Le, H. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00421-0 · Cited by 396
Familial Clustering of Autoimmune Disorders and Evaluation of Medical Risk Factors in Autism
Comi, A. M., Zimmerman, A. W., Frye, V. H., Law, P. A., & Peeden, J. (1999) · Journal of Child Neurology · doi:10.1177/088307389901400608 · Cited by 390
Innate immune responses to infection
Tosi, M. F. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.05.036 · Cited by 387
Elevated cytokine levels in children with autism spectrum disorder
Molloy, C. A., Morrow, A. L., Meinzen-Derr, J., Schleifer, K., Dienger, K., Manning-Courtney, P., Altaye, M., & Wills-Karp, M. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.11.007 · Cited by 386
Maternal Autoimmune Diseases, Asthma and Allergies, and Childhood Autism Spectrum Disorders
Croen, L., Grether, J. K., Yoshida, C. K., Odouli, R., & de Water, J. V. (2005) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.159.2.151 · Cited by 373
Sakai, T., Johnson, K. J., Murozono, M., Sakai, K., Magnuson, M. A., Wieloch, T. W., Cronberg, T., Isshiki, A., Erickson, H., & Fässler, R. (2001) · Nature Medicine · doi:10.1038/85471 · Cited by 362
Vorstman, J. A. S., Staal, W. G., van Daalen, E., van Engeland, H., Hochstenbach, P. F. R., & Franke, L. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001757 · Cited by 353
Absence of C1q Leads to Less Neuropathology in Transgenic Mouse Models of Alzheimer's Disease
Fonseca, M. I., Zhou, J., Botto, M., & Tenner, A. J. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0901-04.2004 · Cited by 345
Olofsson, S. ‐., & Borén, J. (2005) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2005.01556.x · Cited by 342
Geschwind, D. H., Sowinski, J., Lord, C., Iversen, P., Shestack, J., Jones, P., Ducat, L., & Spence, S. J. (2001) · The American Journal of Human Genetics · doi:10.1086/321292 · Cited by 302
Cerebrospinal Fluid and Serum Markers of Inflammation in Autism
Zimmerman, A. W., Jyonouchi, H., Comi, A. M., Connors, S. L., Milstien, S., Varsou, A., & Heyes, M. P. (2005) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2005.03.014 · Cited by 300
C1q, Autoimmunity and Apoptosis
Botto, M. (2002) · Immunobiology · doi:10.1078/0171-2985-00141 · Cited by 294
Cortisol circadian rhythms and response to stress in children with autism
Corbett, B. A., Mendoza, S., Abdullah, M., Wegelin, J. A., & Levine, S. (2006) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2005.05.011 · Cited by 258
Self-citationON DESIGN CONSIDERATIONS AND RANDOMIZATION-BASED INFERENCE FOR COMMUNITY INTERVENTION TRIALS
Gail, M. H., Mark, S. D., Carroll, R. J., Green, S. B., & Pee, D. (1996) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19960615)15:11 · Cited by 246
Reelin glycoprotein: structure, biology and roles in health and disease
Fatemi, S. H. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001613 · Cited by 241
The role of complement in inflammation and adaptive immunity
Barrington, R. A., Zhang, M., Fischer, M. B., & Carroll, M. C. (2001) · Immunological Reviews · doi:10.1034/j.1600-065x.2001.1800101.x · Cited by 231
Jyonouchi, H., Sun, S., & Itokazu, N. (2002) · Neuropsychobiology · doi:10.1159/000065416 · Cited by 225
Characterization of the human blood plasma proteome
Shen, Y., Kim, J., Strittmatter, E. F., Jacobs, J., Camp, D., Fang, R., Tolié, N., Moore, R. J., & Smith, R. D. (2005) · PROTEOMICS · doi:10.1002/pmic.200401246 · Cited by 225
Activation of Complement in the Central Nervous System
van Beek, J., Elward, K., & Gasque, P. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb03138.x · Cited by 220
ASHWOOD, P., ANTHONY, A., TORRENTE, F., & WAKEFIELD, A. J. (2004) · Journal of Clinical Immunology · doi:10.1007/s10875-004-6241-6 · Cited by 212
Self-citationAnalysis of the RELN gene as a genetic risk factor for autism
Skaar, D. A., Shao, Y., Haines, J. L., Stenger, J. E., Jaworski, J. M., Martin, E. R., DeLong, G. R., Moore, J. H., McCauley, J. L., Sutcliffe, J. S., et al. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001614 · Cited by 204
Torrente, F., Ashwood, P., Day, R. M., Machado, N., Furlano, R. I., Anthony, A., Davies, S. E., Wakefield, A. J., Thomson, M. A., Walker-Smith, J. A., et al. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001077 · Cited by 201
Self-citationPlasma increase of interleukin-12 and interferon-gamma. Pathological significance in autism
Singh, V. K. (1996) · Journal of Neuroimmunology · doi:10.1016/0165-5728(96)00014-8 · Cited by 199
Proteomic patterns: their potential for disease diagnosis
Xiao, Z., Prieto, D. A., Conrads, T. P., Veenstra, T. D., & Issaq, H. J. (2004) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2004.10.010 · Cited by 187
Is autism an autoimmune disease?
Ashwood, P., & Van de Water, J. (2004) · Autoimmunity Reviews · doi:10.1016/j.autrev.2004.07.036 · Cited by 181
Self-citationMcCauley, J. L., Li, C., Jiang, L., Olson, L. M., Crockett, G., Gainer, K., Folstein, S. E., Haines, J. L., & Sutcliffe, J. S. (2005) · BMC Medical Genetics · doi:10.1186/1471-2350-6-1 · Cited by 168
Gastrointestinal Factors in Autistic Disorder: A Critical Review
Erickson, C. A., Stigler, K. A., Corkins, M. R., Posey, D. J., Fitzgerald, J. F., & McDougle, C. J. (2005) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-005-0019-4 · Cited by 165
Autism interventions: a critical update
Francis, K. (2005) · Developmental Medicine & Child Neurology · doi:10.1017/s0012162205000952 · Cited by 158
Replication of Autism Linkage: Fine-Mapping Peak at 17q21
Cantor, R. M., Kono, N., Duvall, J. A., Alvarez-Retuerto, A., Stone, J. L., Alarcón, M., Nelson, S. F., & Geschwind, D. H. (2005) · The American Journal of Human Genetics · doi:10.1086/430278 · Cited by 157
Junaid, M. A., Kowal, D., Barua, M., Pullarkat, P. S., Brooks, S. S., & Pullarkat, R. K. (2004) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.30349 · Cited by 157
Reelin Is a Serine Protease of the Extracellular Matrix
Quattrocchi, C. C., Wannenes, F., Persico, A. M., Ciafré, S. A., D'Arcangelo, G., Farace, M. G., & Keller, F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106996200 · Cited by 154
van den Berg, R. H., Faber‐Krol, M. C., Sim, R. B., & Daha, M. R. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.12.6924 · Cited by 130
Strong association of the third hypervariable region of HLA-DRβ1 with autism
Warren, R. P., Odell, J. D., Warren, W. L., Burger, R. A., Maciulis, A., Daniels, W. W., & Torres, A. R. (1996) · Journal of Neuroimmunology · doi:10.1016/0165-5728(96)00052-5 · Cited by 130
van Gent, T., Heijnen, C. J., & Treffers, P. D. A. (1997) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.1997.tb01518.x · Cited by 129
Torres, A., Maciulis, A., Stubbs, E. G., Cutler, A., & Odell, D. (2002) · Human Immunology · doi:10.1016/s0198-8859(02)00374-9 · Cited by 128
Jyonouchi, H., Geng, L., Cushing‐Ruby, A., Reddy, C., & Zimmerman-Bier, B. (2005) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2005.01.027 · Cited by 123
A Review of Autism and the Immune Response
Ashwood, P., & de Water, J. V. (2004) · Journal of Immunology Research · doi:10.1080/10446670410001722096 · Cited by 122
Self-citationAchenbach, T. M. (2005) · Journal of Clinical Child & Adolescent Psychology · doi:10.1207/s15374424jccp3403_9 · Cited by 117
Confirmation of the association of the C4B null allelle in autism
Odell, D., Maciulis, A., Cutler, A., Warren, L., McMahon, W. M., Coon, H., Stubbs, G., Henley, K., & Torres, A. (2005) · Human Immunology · doi:10.1016/j.humimm.2004.11.002 · Cited by 110
Prevalence of serum antibodies to caudate nucleus in autistic children
Singh, V. K., & Rivas, W. H. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2003.10.026 · Cited by 108
Fibronectin binds to the C1q component of complement.
Bing, D. H., Almeda, S., Isliker, H., Lahav, J., & Hynes, R. O. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.13.4198 · Cited by 105
New algorithms for processing and peak detection in liquid chromatography/mass spectrometry data
Hastings, C. A., Norton, S. M., & Roy, S. (2002) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.600 · Cited by 101
Segurado, R., Conroy, J., Meally, E., Fitzgerald, M., Gill, M., & Gallagher, L. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.11.2182 · Cited by 101
Apo A-IV: an update on regulation and physiologic functions
Stan, S., DELVIN, E. E., Lambert, M. A., Seidman, E. G., & Levy, E. H. (2003) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(03)00004-0 · Cited by 98
Immunogenetic studies in autism and related disorders
Warren, R. P., Singh, V. K., Averett, R. E., Odell, J. D., Maciulis, A., Burger, R. A., Daniels, W. W., & Warren, W. L. (1996) · Molecular and Chemical Neuropathology · doi:10.1007/bf02815207 · Cited by 95
Warren, R. P., Yonk, J., Burger, R. W., Odell, D., & Warren, W. L. (2008) · Neuropsychobiology · doi:10.1159/000119172 · Cited by 93
The search for autism disease genes
Wassink, T. H., Brzustowicz, L. M., Bartlett, C. W., & Szatmari, P. (2004) · Mental Retardation and Developmental Disabilities Research Reviews · doi:10.1002/mrdd.20041 · Cited by 89
C1q-Deficiency Is Neuroprotective Against Hypoxic-Ischemic Brain Injury in Neonatal Mice
Ten, V. S., Sosunov, S. A., Mazer, S. P., Stark, R. I., Caspersen, C. S., Sughrue, M. E., Botto, M., Connolly, E. S., & Pinsky, D. J. (2005) · Stroke · doi:10.1161/01.str.0000182237.20807.d0 · Cited by 87
Complement Factor H: Physiology and Pathophysiology
Zipfel, P. F. (2001) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2001-15248 · Cited by 83
Webster, S. D., Park, M., Fonseca, M. I., & Tenner, A. J. (2000) · Journal of Leukocyte Biology · doi:10.1002/jlb.67.1.109 · Cited by 81
Innate immunity and brain inflammation: the key role of complement
Francis, K. L., van Beek, J., Canova, C., Neal, J. W., & Gasque, P. (2003) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399403006252 · Cited by 80
Autoantibody repertoires to brain tissue in autism nuclear families
Silva, S. C., Correia, C., Fesel, C., Barreto, M., Coutinho, A. M., Marques, C., Miguel, T. S., Ataide, A., Bento, C., Borges, L., et al. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.03.015 · Cited by 76
van Beek, J., van Meurs, M., Hart, B. A. ‘., Brok, H., Neal, J. W., Chatagner, A., Harris, C. L., Omidvar, N., Morgan, B. P., Laman, J. D., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.4.2353 · Cited by 68
Role of Complement and Other Innate Immune Mechanisms in the Removal of Apoptotic Cells
Ogden, C. A., & Elkon, K. B. (2005) · KARGER eBooks · doi:10.1159/000090776 · Cited by 58
Significant association of HLA A2–DR11 with CD4 naive decrease in autistic children
Ferrante, P., Saresella, M., Guerini, F. R., Marzorati, M., Musetti, M. C., & Cazzullo, A. G. (2003) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(03)00099-4 · Cited by 52
The association of MHC genes with autism
Anthony, R. T. (2001) · Frontiers in bioscience · doi:10.2741/torres · Cited by 49
Intestinal cytokines in children with pervasive developmental disorders
DeFelice, M. L., Ruchelli, E. D., Markowitz, J. E., Strogatz, M., Reddy, K. P., Kadivar, K., Mulberg, A. E., & Brown, K. A. (2003) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.07593.x · Cited by 47
Early Intervention Critical to Autism Treatment
Butter, E. M., Wynn, J. W., & Mulick, J. A. (2003) · Pediatric Annals · doi:10.3928/0090-4481-20031001-09 · Cited by 46
Marsh, J. B. (2003) · Nutrition Reviews · doi:10.1301/nr.2003.nov.363-375 · Cited by 41
The Role of Apolipoprotein AIV on the Control of Food Intake
Qin, X., & Tso, P. (2005) · Current Drug Targets · doi:10.2174/1389450053174541 · Cited by 32
Quantification of Proteins and Metabolites by Mass Spectrometry Without Isotopic Labeling
Roy, S. M., & Becker, C. H. (2007) · Methods in molecular biology · doi:10.1007/978-1-59745-255-7_6 · Cited by 32
Proteomic Approach for the Elucidation of Biological Defects in Autism
Junaid, M. A., & Pullarkat, R. K. (2001) · Journal of Autism and Developmental Disorders · doi:10.1023/a:1013242910574 · Cited by 29
Quantitative Proteomics by Mass Spectrometry
Sechi, S. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3524-6 · Cited by 29
ACTH Decreases the Expression and Secretion of Apolipoprotein B in HepG2 Cell Cultures
Xu, N., Ekström, U., & Nilsson‐Ehle, P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104659200 · Cited by 27
The association of MHC genes with autism
Torres, A. (2001) · Frontiers in bioscience · doi:10.2741/a655 · Cited by 20
The Abnormal Regulation of Gene Expression in Autistic Brain Tissue
Purcell, A. E., Jeon, O., & Pevsner, J. (2001) · Journal of Autism and Developmental Disorders · doi:10.1023/a:1013290826504 · Cited by 19
Cholesterol metabolism in the rat adrenal cortex: acute temporal changes following stress
Alfano, J. A., Pedersen, R. C., Kramer, R. E., & Brownie, A. C. (1983) · Canadian Journal of Biochemistry and Cell Biology · doi:10.1139/o83-089 · Cited by 19
O’Connor, K. C., Roy, S. M., Becker, C. H., Hafler, D. A., & Kantor, A. B. (2006) · Disease Markers · doi:10.1155/2006/670439 · Cited by 18
Self-citationSerrano, J., Encinas, J. M., Fernández, A. P., Castro‐Blanco, S., Alonso, D. C., Fernández‐Vizarra, P., Richart, A., Bentura, M. L., Santacana, M., Cuttitta, F. F., et al. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00773-x · Cited by 16
Comprehensive phenotyping and biological marker discovery
Kantor, A. B. (2002) · Disease Markers · doi:10.1155/2002/178798 · Cited by 16
Self-citationImmune systems biology: immunoprofiling of cells and molecules
Kantor, A. B., Alters, S. E., Cheal, K., & Dietz, L. J. (2004) · BioTechniques · doi:10.2144/04363pf01 · Cited by 13
Self-citationThe Challenge of Analyzing the Proteome in Humans with Autoimmune Diseases
Chan, S. M., & Utz, P. J. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1358.009 · Cited by 9
Research works printed but not linked: 1
- Lord C, Rutter M, DiLavore PC, Risi S . Autism Diagnostic Observation Schedule (ADOS). Western Psychological Services: Los Angeles, CA, 2002.
Cited by
Sorted by citations
Ashwood, P., Krakowiak, P., Hertz-Picciotto, I., Hansen, R., Pessah, I., & Van de Water, J. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.08.003 · Cited by 940
“, 2010) and increased levels of complement components (Corbett et al., 2007).”
BackgroundSelf-citationConsensus Paper: Pathological Role of the Cerebellum in Autism
Fatemi, S. H., Aldinger, K. A., Ashwood, P., Bauman, M. L., Blaha, C. D., Blatt, G. J., Chauhan, A., Chauhan, V., Dager, S. R., Dickson, P. E., et al. (2012) · The Cerebellum · doi:10.1007/s12311-012-0355-9 · Cited by 723
“Elevated plasma cytokine levels (IL-1β, IL-6, IL-12p40, and TNFα) [82–84], altered immunoglobulin levels [85, 86], elevated levels of complement proteins [87], and increased chemokine levels (CCL2, CCL5, and CCL11) [88] are reported in the plasma of young children with AD compared with matched typically developing chi…”
BackgroundSelf-citationThe role of immune dysfunction in the pathophysiology of autism
Onore, C., Careaga, M., & Ashwood, P. (2012) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2011.08.007 · Cited by 635
“…be associated with the presence of brain-reactive antibodies in the CNS. Similarly, dysregulated complement production in ASD may have a similar effect (Corbett et al., 2007; Odell et al., 2005), as complement opsonization can mediate the phagocytosis of neurons by microglia (Gasque et al., 2002).”
InfluentialSelf-citationMicroglial Activation in Young Adults With Autism Spectrum Disorder
Suzuki, K., Sugihara, G., Ouchi, Y., Nakamura, K., Futatsubashi, M., Takebayashi, K., Yoshihara, Y., Omata, K., Matsumoto, K., Tsuchiya, K. J., et al. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.272 · Cited by 523
ADHD and autism: differential diagnosis or overlapping traits? A selective review
Taurines, R., Schwenck, C., Westerwald, E., Sachse, M., Siniatchkin, M., & Freitag, C. (2012) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-012-0086-2 · Cited by 301
“Proteins Methods Reference ASD fmr1 -/-mouse in vitro 132 differentially expressed proteins, among others: dynamin1, N-ethylmaleimide sensitive fusion protein attachment protein (SNAP)-beta, syntaxin binding protein 1, calbindin 2, CDCrel-1AI SILAC Liao et al. (2008) Human total brain gray matter Glyoxalase 1 2D-PAGE…”
Influential
Metadata
- Authors
- Corbett, B. A., Kantor, A. B., Schulman, H., Walker, W. L., Lit, L., Ashwood, P., Rocke, D. M., & Sharp, F. R.
- Affiliations
- University of California Davis Medical Center (US)
- Pharmaceutical Product Development (United States) (US)
- University of California, Davis (US)
- Corresponding author
- Corbett, B A
- Venue
- Molecular Psychiatry
- Published
- 2006-12-26
- Volume
- 12
- Issue
- 3
- Pages
- 292-306
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- OpenAlex
- W2011080454
- Cited by
- 197
- References
- 97
- Citations by year
- 2026: 3 · 2025: 13 · 2024: 7 · 2023: 13 · 2022: 8 · 2021: 18 · 2020: 11 · 2019: 13 · 2018: 6 · 2017: 13 · 2016: 4 · 2015: 12 · 2014: 18 · 2013: 14 · 2012: 14
- FWCI
- 2.27
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Molecular Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- U.S. Public Health Service (5K08NMHO72958)
- National Human Genome Research Institute (R01HG003352)
- National Institute of Neurological Disorders and Stroke (NS044283, R01NS043252, NS028167, P50NS044283, NS043252, R01NS028167)
- National Institute of Environmental Health Sciences (P42-ES-04699, P42ES004699)
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
- Keywords
- autism spectrum disorder, serum proteomics, apolipoproteins, apolipoprotein B-100, apolipoprotein A-IV, complement system, complement factor H-related proteins, C1q, FN1, differentially expressed proteins, children, high-functioning autism, peripheral blood biomarkers
- MeSH terms
- Apolipoproteins, Autistic Disorder, Child, Child, Preschool, Complement System Proteins, Female, Humans, Male, Mass Spectrometry, Gene Expression, Statistics, Nonparametric, Proteomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review